Dermata Therapeutics DRMA
NASDAQ DRMA
$1.38 -0.09 (-6.12%)
At close: Aug 20, 2026 · 4:00 PM EDT

Dermata Therapeutics (DRMA) Preferred Dividend Payments (2021)

Dermata Therapeutics (DRMA) posted quarterly Preferred Dividend Payments of $2.3 million for Q3 2021.

Dermata Therapeutics (DRMA) Preferred Dividend Payments (2021) Analysis & Trends

Dermata Therapeutics' Preferred Dividend Payments history runs 1 years deep, the most recent figure standing at $2.3 million for Q3 2021.

  • In Q3 2021, Preferred Dividend Payments changed N/A year-over-year to $2.3 million; the TTM figure through Dec 2021 stood at $2.3 million (changed N/A YoY), while the FY2021 annual figure was $2.3 million, changed N/A from the prior year.
  • Preferred Dividend Payments for Q3 2021 stood at $2.3 million.
  • The five-year high for Preferred Dividend Payments was $2.3 million in Q3 2021, with the low at $2.3 million in Q3 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Pref Dividends (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn -
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn -
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn -
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn -
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn -
8 Royalty Pharma 26.98 Bn 26.14 Bn - -
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn -
10 Dermata Therapeutics 5.33 Mn 5.33 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2021 2.29 Mn